ZA200209632B - Methods for prevention of ulcers and improving physiological performance. - Google Patents

Methods for prevention of ulcers and improving physiological performance.

Info

Publication number
ZA200209632B
ZA200209632B ZA200209632A ZA200209632A ZA200209632B ZA 200209632 B ZA200209632 B ZA 200209632B ZA 200209632 A ZA200209632 A ZA 200209632A ZA 200209632 A ZA200209632 A ZA 200209632A ZA 200209632 B ZA200209632 B ZA 200209632B
Authority
ZA
South Africa
Prior art keywords
ulcers
prevention
methods
physiological performance
improving physiological
Prior art date
Application number
ZA200209632A
Other languages
English (en)
Inventor
Frank Pipers
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of ZA200209632B publication Critical patent/ZA200209632B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
ZA200209632A 2000-05-30 2002-11-27 Methods for prevention of ulcers and improving physiological performance. ZA200209632B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20787800P 2000-05-30 2000-05-30

Publications (1)

Publication Number Publication Date
ZA200209632B true ZA200209632B (en) 2004-04-23

Family

ID=22772351

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200209632A ZA200209632B (en) 2000-05-30 2002-11-27 Methods for prevention of ulcers and improving physiological performance.

Country Status (16)

Country Link
US (2) US6939881B2 (de)
EP (1) EP1286669B1 (de)
AR (1) AR028641A1 (de)
AT (1) ATE473002T1 (de)
AU (2) AU6746501A (de)
BR (1) BR0111215A (de)
CA (1) CA2408920C (de)
CY (1) CY1110797T1 (de)
DE (1) DE60142515D1 (de)
DK (1) DK1286669T3 (de)
ES (1) ES2345873T3 (de)
MX (1) MXPA02011608A (de)
NZ (1) NZ522450A (de)
PT (1) PT1286669E (de)
WO (1) WO2001091748A2 (de)
ZA (1) ZA200209632B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE473002T1 (de) * 2000-05-30 2010-07-15 Merial Ltd Zusammensetzungen zur vorbeugung von geschwüren in pferden
US9387386B2 (en) * 2003-07-31 2016-07-12 First Principles, Inc. Method and apparatus for improving performance
US20090197170A1 (en) * 2008-01-31 2009-08-06 Viavattine Joseph J Maximization of active material to collector interfacial area
WO2014076092A1 (en) * 2012-11-14 2014-05-22 Boehringer Ingelheim Vetmedica Gmbh A proton pump inhibitor for use in a method of treating dermatological diseases in canine
KR102419769B1 (ko) * 2016-08-11 2022-07-13 아다미스 파마슈티칼스 코포레이션 약물 조성물
EP3720844A4 (de) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation Arzneimittelzusammensetzungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073929A (en) * 1976-02-13 1978-02-14 Merck & Co., Inc. 3-(2-Substitutedbenzimidazolyl) alanines
US4743609A (en) * 1985-02-12 1988-05-10 Banyu Pharmaceutical Co., Ltd. Indole derivatives having gastric and antisecretory and cytoprotective properties, and pharmaceutical preparations containing same
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
SK286371B6 (sk) * 1999-02-23 2008-08-05 Merck & Co., Inc. Farmaceutický prostriedok
ATE473002T1 (de) * 2000-05-30 2010-07-15 Merial Ltd Zusammensetzungen zur vorbeugung von geschwüren in pferden

Also Published As

Publication number Publication date
EP1286669B1 (de) 2010-07-07
EP1286669A2 (de) 2003-03-05
CA2408920C (en) 2011-07-19
ATE473002T1 (de) 2010-07-15
BR0111215A (pt) 2003-12-16
CY1110797T1 (el) 2015-06-10
ES2345873T3 (es) 2010-10-05
US20050187216A1 (en) 2005-08-25
US20020065306A1 (en) 2002-05-30
NZ522450A (en) 2004-07-30
DE60142515D1 (de) 2010-08-19
CA2408920A1 (en) 2001-12-06
AU6746501A (en) 2001-12-11
PT1286669E (pt) 2010-09-20
DK1286669T3 (da) 2010-08-09
WO2001091748A2 (en) 2001-12-06
AU2001267465B2 (en) 2006-02-02
AR028641A1 (es) 2003-05-21
WO2001091748A3 (en) 2002-04-18
US6939881B2 (en) 2005-09-06
MXPA02011608A (es) 2003-10-06

Similar Documents

Publication Publication Date Title
AU2002223827A1 (en) Well treatment
AU2001260513A1 (en) Microcapsule well treatment
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU2001245401A1 (en) Hydrazones and analogs as cholesterol lowering agents
AU2001241963A1 (en) Improved medical procedure
GB0028269D0 (en) Well treatment
AU2001284865A1 (en) Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
AU2001244888A1 (en) Active noise reduction system
AU8136801A (en) Methods of preventing or treating diseases and conditions using complex carbohydrates
AU2002237667A1 (en) Methods for the treatment and prevention of urinary stone disease
PL362855A1 (en) Improved treatment
AU2001286983A1 (en) Method of treatment
AU2001244461A1 (en) Venous line catheter and method of operating the same
AU2002231206A1 (en) Treatment of depression
AU2001243394A1 (en) Compounds and methods
MXPA02011608A (es) Metodos para la prevencion de ulceras.
AU2001236929A1 (en) Surface treatment
AU2001245414A1 (en) Treatment of allergies
AU2001278951A1 (en) Compounds and methods
EP1318819A4 (de) Behandlung von trauma und anderen indikationen
ZA200210361B (en) Method of administering bishosphonates.
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2002235277A1 (en) Compounds and methods
AU2001262177A1 (en) Method of treatment
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases